%0 Editorial
%T Long-term efficacy of immune checkpoint inhibitors with or without chemotherapy in recurrent or metastatic squamous cell carcinoma of the head and neck: a commentary on the 4-year follow-up of the KEYNOTE-048 trial.
%A Sano D
%A Oridate N
%J Transl Cancer Res
%V 12
%N 5
%D 2023 May 31
%M 37304541
%F 0.496
%R 10.21037/tcr-23-48